Authors: Sanger, TM Grundy, SL Gibson, PJ Namjoshi, MA Greaney, MG Tohen, MF

Citation: Tm. Sanger et al., Long-term olanzapine therapy in the treatment of bipolar I disorder: An open-label continuation phase study, J CLIN PSY, 62(4), 2001, pp. 273-281

Authors: Hammer, PR Stone, MB Reich, DH Broholm, C Gibson, PJ Turnbull, MM Landee, CP Oshikawa, M

Citation: Pr. Hammer et al., Characterization of a quasi-one-dimensional spin-1/2 magnet which is gapless and paramagnetic for g mu H-B less than or similar to J and k(B)T << J, PHYS REV B, 59(2), 1999, pp. 1008-1015

Authors: Mauskopf, JA David, K Grainger, DL Gibson, PJ

Citation: Ja. Mauskopf et al., Annual health outcomes and treatment costs for schizophrenia populations, J CLIN PSY, 60, 1999, pp. 14-19

Authors: Tunis, SL Johnstone, BM Gibson, PJ Loosbrock, DL Dulisse, BK

Citation: Sl. Tunis et al., Changes in perceived health and functioning as a cost-effectiveness measure for olanzapine versus haloperidol treatment of schizophrenia, J CLIN PSY, 60, 1999, pp. 38-45

Authors: Gibson, PJ Koepsell, TD Diehr, P Hale, C

Citation: Pj. Gibson et al., Increasing response rates for mailed surveys of Medicaid clients and otherlow-income populations, AM J EPIDEM, 149(11), 1999, pp. 1057-1062